Suppr超能文献

口服维生素 C 增强了人体皮肤局部冷却时的肾上腺素能血管收缩反应。

Oral vitamin C enhances the adrenergic vasoconstrictor response to local cooling in human skin.

机构信息

Laboratory for Human Physiology, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

J Appl Physiol (1985). 2012 May;112(10):1689-97. doi: 10.1152/japplphysiol.00043.2012. Epub 2012 Mar 1.

Abstract

Local administration of ascorbic acid (Asc) at a supraphysiological concentration inhibits the cutaneous vasoconstrictor response to local cooling (LC). However, whether orally ingesting Asc inhibits the LC-induced vasoconstrictor response remains unknown. The purpose of the present study was to examine the acute influence of oral Asc on the adrenergic vasoconstrictor response to LC in human skin. In experiment 1, skin blood flow (SkBF) was measured by laser-Doppler flowmetry at three sites (forearm, calf, palm). The three skin sites were locally cooled from 34 to 24°C at -1°C/min and maintained at 24°C for 20 min before (Pre) and 1.5 h after (Post) oral Asc (2-g single dose) or placebo supplementation. Cutaneous vascular conductance (CVC) was calculated as the ratio of SkBF to blood pressure and expressed relative to the baseline value before LC. Oral Asc enhanced (P < 0.05) the reductions in CVC in the forearm (Pre, -50.3 ± 3.3%; Post, -57.8 ± 2.2%), calf (Pre, -52.6 ± 3.7%; Post, -66.1 ± 4.3%), and palm (Pre, -46.2 ± 6.2%; Post, -60.4 ± 5.6%) during LC. The placebo did not change the responses at any site. In experiment 2, to examine whether the increased vasoconstrictor response caused by oral Asc is due to the adrenergic system, the release of neurotransmitters from adrenergic nerves in forearm skin was blocked locally by iontophoresis of bretylium tosylate (BT). Oral Asc enhanced (P < 0.05) the reductions in CVC at untreated control sites but did not change the responses at BT-treated sites during LC. In experiment 3, to further examine whether adrenergically mediated vasoconstriction is enhanced by oral Asc, 0.1 mM tyramine was administered using intradermal microdialysis in the forearm skin at 34°C in the Pre and Post periods. Oral Asc increased (P < 0.05) the tyramine-induced reduction in CVC. These findings suggest that oral Asc acutely enhances the cutaneous vasoconstrictor responses to LC through the modification of adrenergic sympathetic mechanisms.

摘要

局部给予超生理浓度的抗坏血酸(Asc)可抑制局部冷却(LC)引起的皮肤血管收缩反应。然而,口服 Asc 是否抑制 LC 引起的血管收缩反应尚不清楚。本研究的目的是探讨口服 Asc 对人体皮肤 LC 诱导的肾上腺素能血管收缩反应的急性影响。在实验 1 中,使用激光多普勒流量仪在三个部位(前臂、小腿、手掌)测量皮肤血流(SkBF)。三个皮肤部位以-1°C/min 的速度从 34°C 局部冷却至 24°C,并在口服 Asc(2g 单剂量)或安慰剂补充前(Pre)和 1.5 小时后(Post)保持在 24°C 20 分钟。皮肤血管传导率(CVC)计算为 SkBF 与血压的比值,并表示为 LC 前的基线值的相对值。口服 Asc 增强(P < 0.05)了前臂(Pre,-50.3 ± 3.3%;Post,-57.8 ± 2.2%)、小腿(Pre,-52.6 ± 3.7%;Post,-66.1 ± 4.3%)和手掌(Pre,-46.2 ± 6.2%;Post,-60.4 ± 5.6%)在 LC 期间的 CVC 降低。安慰剂在任何部位都没有改变反应。在实验 2 中,为了研究口服 Asc 引起的血管收缩反应增加是否是由于肾上腺素能系统,通过离子电渗将布瑞替丁甲苯磺酸盐(BT)局部导入前臂皮肤的肾上腺素能神经来阻断神经递质的释放。口服 Asc 增强(P < 0.05)了未处理对照部位的 CVC 降低,但在 LC 期间 BT 处理部位的反应没有改变。在实验 3 中,为了进一步研究口服 Asc 是否增强了肾上腺素能介导的血管收缩,在 34°C 时,在前测和后测期间通过前臂皮肤的皮内微透析给予 0.1mM 酪胺。口服 Asc 增加(P < 0.05)了酪胺诱导的 CVC 降低。这些发现表明,口服 Asc 通过修饰肾上腺素能交感机制,急性增强皮肤对 LC 的血管收缩反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验